Korro Bio Inc.
NASDAQ:KRRO
| Market Cap (Intraday) | 211.35M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $20.95 |
| 50-Day MA | $15.74 |
| 200-Day MA | $25.24 |
Korro Bio Inc. Stock, NASDAQ:KRRO
60 First Street, 2nd floor, Cambridge, Massachusetts 02141
United States of America
Phone: +1.617.468.1999
Number of Employees: 104
Description
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.